
Lung cancer and thyroid – First RET+ drug, Retevmo
The FDA has approved Retevmo capsules for the treatment of patients with lung cancer or thyroid cancer harboring RET alterations. This is the first therapy

Kidney Cancer – Opdivo plus Cabometyx prolong life
Background Patients with advanced or metastatic kidney cancer are a population that despite recent advances remains in need of additional therapeutic options that extend survival.

Compassionate Drugs – What are they?
“Compassionate drugs“, also called “named patient drugs” or “early access drugs”. Compassionate drugs can be one of three cases: Compassionate drugs (1) – Can be

Chondrosarcoma – Ivosidenib works in Chondrosarcoma
Chondrosarcoma and IDH1 – Background For locally advanced and/or metastatic Chondrosarcoma, no known effective therapy exists. The standard protocols are not effective. Mutations in the

GBM that disappeared from Monica’s MRI from 4.3.20
Monica (not her real name), a 43-year-old Cyprus resident, was diagnosed with GBM brain cancer, Glioblastoma, two years ago. One year ago Monica’s husband contacted

Triple Negative Breast Cancer and Stunning Biological Drug, IMMU-132
FDA may approve new biological drug called IMMU-132 for treating patients with triple negative breast cancer On a personal note “My mother died of triple-negative

A combination with a new biological drug, Navicixizumab, Shows Benefit in Ovarian Cancer
New Trial – Ovarian Cancer Data from the phase Ib study were made available as part of the virtual platform for the SGO 2020 Annual Meeting

Corona Virus and Cancer
What is the link between the corona virus and cancer? The world is experiencing an outbreak of a new betacoronavirus known as Severe Acute Respiratory

FDA Grants Breakthrough Therapy Designation to JNJ-6372 in mNSCLC
Published on March 10, 2020 Background The FDA granted Breakthrough Therapy designation to JNJ-61186372 (JNJ-6372) for the treatment of patients with Metastatic Non-Small Cell Lung

Does genetic test extends the lives of Pancreatic Cancer patients?
Currently, it does not seem so and so one should think and think again about doing them especially for their high cost. Published on March

Proton or Photon Radiation?
Published on February 25, 2020 Background Many people with locally advanced cancers are treated with a combination of chemotherapy and either photon or proton radiation.

Metastatic Renal Cell Cancer, mRCC – Promising Treatment Option with Keytruda + Avastin
Published on February 25, 2020 Background This phase Ib/II study was designed to evaluate the safety and efficacy of a novel immunotherapy and VEGF-directed therapy






